Stryker said today that it agreed to acquire Instratek for an undisclosed amount at the end of the 4th quarter.
The medtech giant will take on the Houston -based company’s portfolio of staple and hammertoe implants, as well as its minimally invasive soft tissue recession instrumentation.
“This acquisition supports our commitment to growth in extremities with products that complement our existing portfolio, strengthen our leadership in the forefoot segment and provide immediate access into minimally invasive soft tissue recession procedures,” Stryker Orthopaedics president David Floyd said in prepared remarks.
